The group’s principle activity is to provide modern technology to make the next generation of safer and more effective human and animal vaccines for influenza, SARS and other diseases. The group’s products include ExpresSF+(R),GeneXpress(R), and GeneXpress BaculoKIT(TM). The group’s service includes price schedule. The group operates from United States.
